Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tc Biopharm [Holdings] Plc ADR (TCBP)

Tc Biopharm [Holdings] Plc ADR (TCBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 205
  • Shares Outstanding, K 410
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,350 K
  • EBIT $ -4 M
  • EBITDA $ -4 M
  • 60-Month Beta 0.01
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.01
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -448.00
  • Most Recent Earnings $-28.00 on 05/15/24
  • Next Earnings Date 04/07/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5000 unch
on 03/21/25
2.6900 -81.41%
on 02/24/25
-2.0000 (-80.00%)
since 02/21/25
3-Month
0.5000 unch
on 03/21/25
13.1216 -96.19%
on 12/30/24
-10.0600 (-95.27%)
since 12/20/24
52-Week
0.5000 unch
on 03/21/25
523.2000 -99.90%
on 04/04/24
-258.7000 (-99.81%)
since 03/21/24

Most Recent Stories

More News
Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week

Investors reacted to insider buying, clinical trial updates, and strategic business shifts that happened in the week ended March 21, 2025.

GCTK : 5.62 (-5.15%)
TCBP : 0.5000 (-67.53%)
ABBV : 232.90 (-0.14%)
ATNM : 1.2550 (-3.46%)
RGC : 13.25 (-3.18%)
TC BioPharm Stock Crashes On Nasdaq Delisting: Retail Expresses Frustration

TC BioPharm said its securities will be suspended for trading on the exchange beginning Monday.

TCBP : 0.5000 (-67.53%)
Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments

EQNX::TICKER_START (NASDAQ:TCBP),(NYSE:CVM),(NASDAQ:INVO),(NASDAQ:SNY),(NYSE:PFE) EQNX::TICKER_END

TCBP : 0.5000 (-67.53%)
CVM : 6.63 (-1.71%)
INVO : 0.8330 (-2.91%)
PFE : 25.75 (-0.46%)
SNY : 52.38 (+0.89%)
TC BioPharm Announces Grant Funding in Collaboration with Queen Mary University of London (QMUL)

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical stage biotechnology company developing platform...

TCBP : 0.5000 (-67.53%)
TC BioPharm to Present at H.C. Wainwright 25th Annual Global Investment Conference

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform...

TCBP : 0.5000 (-67.53%)
TC BioPharm Maintains Nasdaq Listing

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform...

TCBP : 0.5000 (-67.53%)
TC BioPharm CEO, Bryan Kobel, is Featured on The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - July 6, 2023) - The Stock Day Podcast welcomed TC BioPharm Holdings, PLC. (NASDAQ: TCBP) ("the Company"), a clinical-stage biopharmaceutical company focused on the discovery,...

TCBP : 0.5000 (-67.53%)
TC BioPharm Increases Allogeneic Car and Partnering Focus for Advancement of TCB-008

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company today laid out a fundamental...

TCBP : 0.5000 (-67.53%)
TC BioPharm Announces Closing of $5.5 Million Public Offering

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform...

TCBP : 0.5000 (-67.53%)
TC BioPharm Announces Pricing of $5.5 Million Public Offering

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform...

TCBP : 0.5000 (-67.53%)

Business Summary

TC BioPharm plc is a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and viral indications. TC BioPharm plc is based in EDINBURGH, Scotland.

See More

Key Turning Points

3rd Resistance Point 2.2333
2nd Resistance Point 1.8867
1st Resistance Point 1.1933
Last Price 0.5000
1st Support Level 0.1533
2nd Support Level N/A
3rd Support Level N/A

See More

52-Week High 523.2000
Fibonacci 61.8% 323.5286
Fibonacci 50% 261.8500
Fibonacci 38.2% 200.1714
Last Price 0.5000
52-Week Low 0.5000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar